Using lung ultrasound to detect lung disease in rheumatoid arthritis patients
Role of Lung Ultrasound in Screening for Interstitial Lung Disease in Patients With Rheumatoid Arthritis
This study is testing if lung ultrasound can help find lung disease earlier in people with rheumatoid arthritis compared to regular CT scans.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Assiut) |
| Trial ID | NCT06531785 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of lung ultrasound as a diagnostic tool for early detection of interstitial lung disease (ILD) in patients with rheumatoid arthritis. Participants will undergo both lung ultrasound and high-resolution CT scans to compare the accuracy of these methods in identifying ILD. The study focuses on patients with a history of chest issues related to their rheumatoid arthritis, aiming to provide a non-invasive and cost-effective alternative to traditional imaging techniques. By assessing the number of B-lines observed in lung ultrasound, researchers hope to establish a reliable screening method for ILD.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with a confirmed diagnosis of rheumatoid arthritis and a clinical suspicion of interstitial lung disease.
Not a fit: Patients with a history of pulmonary neoplasia or other conditions causing interstitial fluid, such as heart failure or asthma, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier and more accessible diagnosis of interstitial lung disease in rheumatoid arthritis patients, improving patient outcomes.
How similar studies have performed: Previous studies have shown that lung ultrasound can be a sensitive and specific tool for diagnosing interstitial lung disease in connective tissue disease patients, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed diagnosis of rheumatoid arthritis and suspicion of interstitial lung disease on history and/ or clinical examination, age \> 18 years Exclusion Criteria: * Patients who refuse to participate in the study, * Patients with a history of pulmonary neoplasia or * Patients with causes of interstitial fluid, such as, heart failure, diastolic dysfunction, asthma or pulmonary edema.
Where this trial is running
Assiut
- Faculty of Medicine, Assiut University — Assiut, Egypt (Recruiting)
Study contacts
- Principal investigator: Waleed MD Gamal Elddin Khaleel, Ass. Prof. — Assiut University
- Study coordinator: Waleed MD Gamal Elddin Khaleel, Ass. Prof.
- Email: waleed_gamal@aun.edu.eg
- Phone: +201006519722
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.